Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation

AIMS: Improved cancer survivorship has led to a higher number of anthracycline‐induced cardiomyopathy patients with end‐stage heart failure. We hypothesize that outcomes following continuous‐flow LVAD (CF‐LVAD) implantation in those with anthracycline‐induced cardiomyopathy are comparable with other...

Descripción completa

Detalles Bibliográficos
Autores principales: Guha, Avirup, Caraballo, Cesar, Jain, Prantesh, Miller, P. Elliott, Owusu‐Guha, Jocelyn, Clark, Katherine A.A., Velazquez, Eric J., Ahmad, Tariq, Baldassarre, Lauren A., Addison, Daniel, Weintraub, Neal L., Desai, Nihar R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318466/
https://www.ncbi.nlm.nih.gov/pubmed/33982867
http://dx.doi.org/10.1002/ehf2.13362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318466/
https://www.ncbi.nlm.nih.gov/pubmed/33982867
http://dx.doi.org/10.1002/ehf2.13362

Ejemplares similares